 The Money Times |
Multiple Sclerosis Drug Tysabri Associated with Risk of Brain Infection, FDA Warns
DrugWatch.com The US Food and Drug Administration (FDA) announced a new warning for the multiple sclerosis (MS) drug Tysabri on February 5, 2010. ... FDA Warns of Brain Risks with Frequent Tysabri Use FDA: Risk builds up with Tysabri infusions Study to look at earlier use of MS drug Tysabri |
Multiple Sclerosis Drug Tysabri Associated with Risk of Brain Infection, FDA Warns - DrugWatch.com
Submitted by synapse on
Add new comment